Last Updated: June 17, 2026

ibuprofen; oxycodone hydrochloride - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for ibuprofen; oxycodone hydrochloride and what is the scope of patent protection?

Ibuprofen; oxycodone hydrochloride is the generic ingredient in two branded drugs marketed by Forest Labs, Actavis Elizabeth, Barr Labs Inc, and Watson Labs, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

Summary for ibuprofen; oxycodone hydrochloride
US Patents:0
Tradenames:2
Applicants:4
NDAs:4

US Patents and Regulatory Information for ibuprofen; oxycodone hydrochloride

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Labs COMBUNOX ibuprofen; oxycodone hydrochloride TABLET;ORAL 021378-001 Nov 26, 2004 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Actavis Elizabeth OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078769-001 Jan 4, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Barr Labs Inc OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078316-001 Nov 29, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078394-001 Nov 26, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links